cbdMD, Inc. (YCBD) stock
YCBDNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/3081% below fair value
$0.37+0.01 (+2.77%)
Close on Nov 18, 2026Market cap $4.19MP/E –Yield –
cbdMD operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
cbdMD's operating income for the twelve months ending Jun 30, 2026 was -$2.90M. For fiscal 2025 it was -$2.16M. The highest annual figure on record is -$1.36M in fiscal 2017.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$2.16M | – |
| FY2024 | Sep 30, 2024 | -$3.32M | – |
| FY2023 | Sep 30, 2023 | -$22.49M | – |
| FY2022 | Sep 30, 2022 | -$78.27M | – |
| FY2021 | Sep 30, 2021 | -$19.62M | – |
| FY2020 | Sep 30, 2020 | -$17.58M | – |
| FY2019 | Sep 30, 2019 | -$14.80M | – |
| FY2018 | Sep 30, 2018 | -$1.80M | – |
| FY2017 | Sep 30, 2017 | -$1.36M | – |
| FY2016 | Sep 30, 2016 | -$3.89M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -$1.13M | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -$800.78K | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$286.29K | – |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | -$685.82K | – |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$904.69K | – |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | -$485.82K | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | -$86.27K | – |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | -$316.56K | – |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | -$382.03K | – |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -$1.55M | – |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | -$1.07M | – |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | -$15.22M | – |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | -$1.82M | – |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | -$1.40M | – |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | -$4.05M | – |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | -$14.98M | – |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -$33.13M | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -$7.01M | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | -$6.68M | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | -$4.17M | – |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | -$1.76M | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | -$4.53M | – |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | -$1.34M | – |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | -$5.60M | – |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | -$6.11M | – |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | -$5.21M | – |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | -$6.47M | -1130.9% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | -$2.03M | -225.2% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | -$1.09M | – |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | -$2.75M | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $627.25K | – |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $1.62M | – |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | -$1.30M | – |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -$275.81K | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -$178.55K | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | -$211.31K | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -$695.50K | – |
See a number that looks wrong?